Vericiguat
Also known as Verquvo (us)
Vericiguat is used to reduce the risk of death and need for hospitalization in certain adults with heart failure. Vericiguat is in a class of medications called soluble guanylate cyclase (sGC) stimulators.
United States
$682
per month
India
$40
per month
You save
−94%save $642/mo · 94% cheaper
49.6K US scripts/yr$31.8M potential annual savings$33.8M US spend/yr
Drag to rotate · 3D structureC19H16F2N8O2
SMILES: COC(=O)NC1=C(N=C(N=C1N)C2=NN(C3=C2C=C(C=N3)F)CC4=CC=CC=C4F)N
Compare the price
US price$682per month
India priceNot availableno India data yet
You save—add India price to compare
Based on 30 EAs per month. US $22.73 per unit — India price not available for this variant.
Total over 1 periodIndia price not availableUS total $682
The bigger picture
Vericiguat is filled about 49.6K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$33.8M
If sourced from India
$2M
Potential annual savings
$31.8M
−94%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.